• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 12, 2024 at 11:32: AM
via Pfizer inadvertently gave a leg up to two obesity biotechs yesterday with the announcement that an extended-release formulation of oral med danuglipron will be advanced into dose optimization studies.

article source
 

<



Similar threads

cafead
Pfizer plans to be &#039;very active&#039; in obesity market, but CEO mum on precise...
Replies
0
Views
54
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
AstraZeneca steps out from Daiichi&#039;s shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Replies
0
Views
12
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Vaxcyte&#039;s &#039;stunning&#039; 31-valent pneumococcal vaccine win against Pfizer&#039;s Prevnar 20 has analysts thinking big
Replies
0
Views
19
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Pfizer, BioNTech&#039;s combo mRNA shot is latest to be defeated by influenza strain B
Replies
0
Views
11
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
US court rules for AstraZeneca, erasing Pfizer&#039;s $107.5M jury award in patent infringement case
Replies
0
Views
47
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote